Antoinette Gawin: Turning Innovation Into Action for America’s Blood Supply
Antoinette Gawin, President and Chief Executive Officer at Terumo Blood and Cell Technologies, shared a post on LinkedIn:
”Behind every blood shortage statistic is a patient waiting for care.
As the American Red Cross declares its second-ever national blood supply crisis, blood centers need every available tool to help strengthen operations and serve patients.
The FDA’s decision to reduce review timelines for future implementations of the Reveos Automated Blood Collection System from 12 months or longer to as little as 30 days is an important step forward.
Blood can’t wait. Faster access to innovation helps blood centers spend less time navigating approvals and more time supporting the communities that depend on them.
I’m grateful to the FDA, AABB, America’s Blood Centers, and everyone who helped make this progress possible.”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 12:02Hajra Malik: Bridging Language Gaps in Hematology With AI
-
Sep 29, 2026, 11:57Joan Montaner: Can Blood Test Identify Intracerebral Hemorrhage Within Minutes?
-
Sep 29, 2026, 11:43From Years Without Answers to Life With Hemophilia Care – WFH
-
Sep 29, 2026, 11:32Sara Al Dallal: Transforming Hemophilia Care Across the Gulf
-
Sep 29, 2026, 11:21Richard Davis: Rapid Rescue in Massive Pulmonary Embolism
-
Sep 29, 2026, 11:14Nissan Brown: Every Step Counts for the Hemophilia Community
-
Sep 29, 2026, 11:03Zain Khalpey: SINGLE AF Adds New Evidence to the Anticoagulation Debate
-
Sep 29, 2026, 10:54How Does Haemophilia Affect Motor Development in Infants? – EAHAD
-
Sep 29, 2026, 10:49Alison Davey: The Vital Role of Community Support in Bleeding Disorders